US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist

1.360
0.0000.00%

Trading Nov 4 11:29 ET

29.11MMarket Cap-1152P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

74.41%-1.8M

22.03%-4.51M

1.80%-23.52M

-9.53%-5.28M

17.50%-5.44M

24.26%-7.02M

-76.93%-5.78M

-36.55%-23.95M

26.90%-4.82M

-56.94%-6.59M

Net income from continuing operations

54.42%-3.1M

42.64%-4.14M

6.41%-29.07M

-26.51%-9.1M

-4.01%-5.96M

31.48%-6.79M

12.24%-7.22M

-114.68%-31.06M

-51.79%-7.19M

-67.44%-5.73M

Operating gains losses

-58.12%98K

-105.53%-77K

-118.31%-363K

-52,175.00%-2.09M

103.52%102K

-91.99%234K

-29.20%1.39M

135.47%1.98M

99.88%-4K

-360.89%-2.9M

Depreciation and amortization

-24.53%160K

-10.05%188K

7.46%835K

-9.50%200K

11.46%214K

20.45%212K

11.17%209K

42.31%777K

47.33%221K

22.29%192K

Other non cash items

-63.27%83K

-52.88%98K

494.46%4.94M

1,982.52%4.29M

0.93%216K

0.00%226K

12.43%208K

101.21%831K

-5.94%206K

145.98%214K

Change In working capital

140.31%570K

4.56%-962K

-326.12%-1.82M

-14.44%1.02M

-135.68%-415K

58.15%-1.41M

-155.11%-1.01M

159.25%804K

320.15%1.19M

251.24%1.16M

-Change in prepaid assets

317.40%1.44M

-27.85%355K

118.71%608K

154.13%262K

-46.74%515K

47.66%-661K

-53.50%492K

122.26%278K

24.14%-484K

332.45%967K

-Change in payables and accrued expense

-69.78%-764K

-2.88%-1.21M

-179.43%-1.47M

-59.24%845K

-331.31%-687K

69.30%-450K

-224.37%-1.18M

7,816.67%1.85M

6,587.10%2.07M

196.12%297K

-Change in other current liabilities

66.01%-103K

67.60%-104K

27.98%-955K

77.89%-88K

-140.59%-243K

53.38%-303K

-81.36%-321K

-1,478.57%-1.33M

-703.03%-398K

-129.55%-101K

Cash from discontinued investing activities

Operating cash flow

74.41%-1.8M

22.03%-4.51M

1.80%-23.52M

-9.53%-5.28M

17.50%-5.44M

24.26%-7.02M

-76.93%-5.78M

-36.55%-23.95M

26.90%-4.82M

-56.94%-6.59M

Investing cash flow

Cash flow from continuing investing activities

70.61%-794K

116.26%5.1M

-141.53%-25.97M

243.78%4.14M

-91.04%3.95M

92.95%-2.7M

-152.53%-31.35M

262.79%62.52M

46.20%-2.88M

207.46%44.04M

Net PPE purchase and sale

-136.36%-16K

179.01%128K

98.73%-103K

101.70%44K

97.56%-29K

101.29%44K

82.98%-162K

-399.82%-8.12M

-149.85%-2.58M

-891.67%-1.19M

Net investment purchase and sale

71.63%-779K

115.77%4.92M

-136.61%-25.87M

1,486.78%4.09M

-91.21%3.97M

92.14%-2.75M

-151.44%-31.18M

292.06%70.65M

93.16%-295K

213.15%45.23M

Net other investing changes

--1K

--53K

----

Cash from discontinued investing activities

Investing cash flow

70.61%-794K

116.26%5.1M

-141.53%-25.97M

243.78%4.14M

-91.04%3.95M

92.95%-2.7M

-152.53%-31.35M

262.79%62.52M

46.20%-2.88M

207.46%44.04M

Financing cash flow

Cash flow from continuing financing activities

10,421.43%4.42M

64.78%524K

140.00%360K

-16.00%42K

536.00%318K

-99.75%150K

-25.37%50K

Net common stock issuance

10,421.43%4.42M

64.78%524K

--360K

--0

--42K

--318K

--0

Proceeds from stock option exercised by employees

--0

-98.08%150K

--0

-25.37%50K

Cash from discontinued financing activities

Financing cash flow

10,421.43%4.42M

64.78%524K

140.00%360K

--0

-16.00%42K

536.00%318K

-99.75%150K

--0

-25.37%50K

Net cash flow

Beginning cash position

-82.74%2.34M

-97.57%1.23M

332.77%50.36M

-95.92%2.37M

-81.21%3.86M

-80.11%13.55M

332.77%50.36M

65.94%11.64M

148.86%58.05M

51.29%20.55M

Current changes in cash

118.88%1.83M

103.02%1.11M

-226.88%-49.13M

85.16%-1.14M

-103.98%-1.49M

79.63%-9.68M

-165.21%-36.81M

669.50%38.72M

35.56%-7.69M

267.98%37.5M

Effect of exchange rate changes

----

--0

----

--0

----

End cash Position

7.87%4.17M

-82.74%2.34M

-97.57%1.23M

-95.92%2.37M

-81.21%3.86M

-80.11%13.55M

332.77%50.36M

148.86%58.05M

Free cash flow

74.32%-1.81M

23.43%-4.55M

25.93%-23.76M

28.58%-5.28M

29.74%-5.47M

44.28%-7.06M

-40.87%-5.95M

-67.34%-32.08M

2.95%-7.4M

-80.12%-7.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	74.41%-1.8M	22.03%-4.51M	1.80%-23.52M	-9.53%-5.28M	17.50%-5.44M	24.26%-7.02M	-76.93%-5.78M	-36.55%-23.95M	26.90%-4.82M	-56.94%-6.59M
Net income from continuing operations	54.42%-3.1M	42.64%-4.14M	6.41%-29.07M	-26.51%-9.1M	-4.01%-5.96M	31.48%-6.79M	12.24%-7.22M	-114.68%-31.06M	-51.79%-7.19M	-67.44%-5.73M
Operating gains losses	-58.12%98K	-105.53%-77K	-118.31%-363K	-52,175.00%-2.09M	103.52%102K	-91.99%234K	-29.20%1.39M	135.47%1.98M	99.88%-4K	-360.89%-2.9M
Depreciation and amortization	-24.53%160K	-10.05%188K	7.46%835K	-9.50%200K	11.46%214K	20.45%212K	11.17%209K	42.31%777K	47.33%221K	22.29%192K
Other non cash items	-63.27%83K	-52.88%98K	494.46%4.94M	1,982.52%4.29M	0.93%216K	0.00%226K	12.43%208K	101.21%831K	-5.94%206K	145.98%214K
Change In working capital	140.31%570K	4.56%-962K	-326.12%-1.82M	-14.44%1.02M	-135.68%-415K	58.15%-1.41M	-155.11%-1.01M	159.25%804K	320.15%1.19M	251.24%1.16M
-Change in prepaid assets	317.40%1.44M	-27.85%355K	118.71%608K	154.13%262K	-46.74%515K	47.66%-661K	-53.50%492K	122.26%278K	24.14%-484K	332.45%967K
-Change in payables and accrued expense	-69.78%-764K	-2.88%-1.21M	-179.43%-1.47M	-59.24%845K	-331.31%-687K	69.30%-450K	-224.37%-1.18M	7,816.67%1.85M	6,587.10%2.07M	196.12%297K
-Change in other current liabilities	66.01%-103K	67.60%-104K	27.98%-955K	77.89%-88K	-140.59%-243K	53.38%-303K	-81.36%-321K	-1,478.57%-1.33M	-703.03%-398K	-129.55%-101K
Cash from discontinued investing activities
Operating cash flow	74.41%-1.8M	22.03%-4.51M	1.80%-23.52M	-9.53%-5.28M	17.50%-5.44M	24.26%-7.02M	-76.93%-5.78M	-36.55%-23.95M	26.90%-4.82M	-56.94%-6.59M
Investing cash flow
Cash flow from continuing investing activities	70.61%-794K	116.26%5.1M	-141.53%-25.97M	243.78%4.14M	-91.04%3.95M	92.95%-2.7M	-152.53%-31.35M	262.79%62.52M	46.20%-2.88M	207.46%44.04M
Net PPE purchase and sale	-136.36%-16K	179.01%128K	98.73%-103K	101.70%44K	97.56%-29K	101.29%44K	82.98%-162K	-399.82%-8.12M	-149.85%-2.58M	-891.67%-1.19M
Net investment purchase and sale	71.63%-779K	115.77%4.92M	-136.61%-25.87M	1,486.78%4.09M	-91.21%3.97M	92.14%-2.75M	-151.44%-31.18M	292.06%70.65M	93.16%-295K	213.15%45.23M
Net other investing changes	--1K	--53K	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	70.61%-794K	116.26%5.1M	-141.53%-25.97M	243.78%4.14M	-91.04%3.95M	92.95%-2.7M	-152.53%-31.35M	262.79%62.52M	46.20%-2.88M	207.46%44.04M
Financing cash flow
Cash flow from continuing financing activities	10,421.43%4.42M	64.78%524K	140.00%360K	0	0	-16.00%42K	536.00%318K	-99.75%150K	0	-25.37%50K
Net common stock issuance	10,421.43%4.42M	64.78%524K	--360K	--0	--0	--42K	--318K	--0	--0	--0
Proceeds from stock option exercised by employees	--0	--0	--0	--0	--0	--0	--0	-98.08%150K	--0	-25.37%50K
Cash from discontinued financing activities
Financing cash flow	10,421.43%4.42M	64.78%524K	140.00%360K	--0	--0	-16.00%42K	536.00%318K	-99.75%150K	--0	-25.37%50K
Net cash flow
Beginning cash position	-82.74%2.34M	-97.57%1.23M	332.77%50.36M	-95.92%2.37M	-81.21%3.86M	-80.11%13.55M	332.77%50.36M	65.94%11.64M	148.86%58.05M	51.29%20.55M
Current changes in cash	118.88%1.83M	103.02%1.11M	-226.88%-49.13M	85.16%-1.14M	-103.98%-1.49M	79.63%-9.68M	-165.21%-36.81M	669.50%38.72M	35.56%-7.69M	267.98%37.5M
Effect of exchange rate changes	----	----	--0	----	----	----	----	--0	----	----
End cash Position	7.87%4.17M	-82.74%2.34M	-97.57%1.23M	-97.57%1.23M	-95.92%2.37M	-81.21%3.86M	-80.11%13.55M	332.77%50.36M	332.77%50.36M	148.86%58.05M
Free cash flow	74.32%-1.81M	23.43%-4.55M	25.93%-23.76M	28.58%-5.28M	29.74%-5.47M	44.28%-7.06M	-40.87%-5.95M	-67.34%-32.08M	2.95%-7.4M	-80.12%-7.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data